Related Experiment Video
Updated: May 3, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
19.1K
Tonabersat for migraine prophylaxis: a systematic review
1First Affiliated Hospital, Guangxi Medical Center, Nanning, Guangxi, China.
Pain Physician
|January 24, 2014
Summary
Tonabersat showed good tolerability for migraine prevention, but current evidence is limited. Further research is needed to confirm its efficacy in reducing migraine frequency.
Area of Science:
- Neurology
- Pharmacology
- Clinical Research
Background:
- Systematic review of randomized clinical trials on tonabersat for migraine prophylaxis.
- Aimed to establish an overall estimate of tonabersat's efficacy and tolerability compared to placebo.
- Informed clinicians and caregivers on migraine prevention strategies.
Purpose of the Study:
- Evaluate the efficacy of tonabersat in migraine prevention.
- Assess the tolerability of tonabersat for migraine prophylaxis.
Main Methods:
- Systematic review of randomized, double-blind, placebo-controlled trials.
- Searched Cochrane, PubMed, and EMBASE databases up to January 2013.
- Primary outcome: change in mean migraine headache days; Secondary outcomes: attack frequency, responder rates, rescue medication use, adverse events.
Main Results:
- Identified 2 studies meeting inclusion criteria after reviewing 133 initially.
- Tonabersat did not demonstrate a significant reduction in migraine days compared to placebo due to limited evidence.
- Tonabersat exhibited good tolerability in the included studies.
Conclusions:
- A significant limitation of this review was the lack of available evidence.
- Fair evidence for migraine prophylaxis exists, but specific evidence for tonabersat is scarce.
- Future research should explore tonabersat's utility in the preventive management of migraines.
